{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:28:31Z","timestamp":1774387711537,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6265,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.fertnstert.2004.10.044","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T07:46:04Z","timestamp":1113032764000},"page":"889-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early cessation of triptorelin in in vitro fertilization: A double-blind, randomized study"],"prefix":"10.1016","volume":"83","author":[{"given":"Arnold H.M.","family":"Simons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henny J.M.","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex P.E.","family":"Schmoutziguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte J.","family":"Roozenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eefje P.","family":"van't Hof-van den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon A.","family":"Schoonderwoerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.fertnstert.2004.10.044_bib1","first-page":"245","article-title":"GnRH agonists and in vitro fertilization","volume":"43","author":"Barlow","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"Fischl","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/humrep\/17.5.1413","article-title":"GnRH agonist versus antagonist therapy","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)56650-3","article-title":"Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program","volume":"61","author":"Pantos","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/oxfordjournals.humrep.a137976","article-title":"Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist","volume":"8","author":"Donderwinkel","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0015-0282(16)57443-3","article-title":"Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate","volume":"63","author":"Sungurtekin","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/oxfordjournals.humrep.a137831","article-title":"Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(98)00040-5","article-title":"Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders","volume":"69","author":"Faber","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(99)00289-7","article-title":"Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization","volume":"72","author":"Dirnfeld","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0015-0282(97)81458-6","article-title":"A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization","volume":"67","author":"Fujii","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib14","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/humrep\/15.11.2292","article-title":"High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial","volume":"15","author":"Garcia-Velasco","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1009476411762","article-title":"Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase\u2014a function of improved embryo quality","volume":"18","author":"Schachter","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014026220880","article-title":"Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders","volume":"19","author":"Wang","year":"2002","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humrep\/15.1.43","article-title":"Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization","volume":"15","author":"Beckers","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/humrep\/15.5.1009","article-title":"Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization","volume":"15","author":"Cedrin-Durnerin","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.10.044_bib19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergaard","year":"2000","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204032303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204032303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:09:03Z","timestamp":1758006543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028204032303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0015028204032303"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.10.044","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early cessation of triptorelin in in vitro fertilization: A double-blind, randomized study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}